Oppenheimer Asset Management Inc. Sanofi Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Sanofi stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 125,595 shares of SNY stock, worth $6.08 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

125,595

Previous 135,751 7.48%

Holding current value

$6.08 Million

Previous $6.59 Million 9.95%

% of portfolio

0.09%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$48.54 - $58.53 $492,972 - $594,430	-10,156 Reduced 7.48%	125,595 $7.24 Million
Q2 2024 Aug 08, 2024	BUY	$45.39 - $50.36 $656,112 - $727,953	14,455 Added 11.92%	135,751 $6.59 Million
Q1 2024 May 06, 2024	SELL	$45.75 - $52.48 $888,876 - $1.02 Million	-19,429 Reduced 13.81%	121,296 $5.89 Million
Q4 2023 Feb 13, 2024	SELL	$43.13 - $54.79 $957,356 - $1.22 Million	-22,197 Reduced 13.62%	140,725 $7 Million
Q3 2023 Nov 07, 2023	BUY	$50.95 - $55.2 $53,395 - $57,849	1,048 Added 0.65%	162,922 $8.74 Million
Q2 2023 Aug 02, 2023	SELL	$50.45 - $57.18 $15,639 - $17,725	-310 Reduced 0.19%	161,874 $8.73 Million
Q1 2023 May 10, 2023	BUY	$45.86 - $54.45 $1.04 Million - $1.23 Million	22,592 Added 16.18%	162,184 $8.83 Million
Q4 2022 Feb 06, 2023	SELL	$38.86 - $48.55 $486,410 - $607,700	-12,517 Reduced 8.23%	139,592 $6.76 Million
Q3 2022 Nov 14, 2022	SELL	$37.22 - $100.5 $1.89 Million - $5.09 Million	-50,688 Reduced 24.99%	152,109 $5.78 Million
Q2 2022 Aug 08, 2022	SELL	$48.99 - $57.46 $1.11 Million - $1.3 Million	-22,576 Reduced 10.02%	202,797 $10.1 Million
Q1 2022 May 12, 2022	BUY	$48.48 - $53.65 $184,757 - $204,460	3,811 Added 1.72%	225,373 $11.6 Million
Q4 2021 Feb 02, 2022	SELL	$47.07 - $52.35 $560,603 - $623,488	-11,910 Reduced 5.1%	221,562 $11.1 Million
Q3 2021 Nov 12, 2021	SELL	$47.89 - $53.12 $75,474 - $83,717	-1,576 Reduced 0.67%	233,472 $11.3 Million
Q2 2021 Aug 03, 2021	BUY	$49.36 - $54.25 $145,463 - $159,874	2,947 Added 1.27%	235,048 $12.4 Million
Q1 2021 May 17, 2021	BUY	$45.46 - $50.51 $1.41 Million - $1.56 Million	30,974 Added 15.4%	232,101 $11.5 Million
Q4 2020 Feb 11, 2021	BUY	$45.3 - $51.62 $652,274 - $743,276	14,399 Added 7.71%	201,127 $9.77 Million
Q3 2020 Nov 13, 2020	BUY	$49.47 - $53.77 $1.23 Million - $1.34 Million	24,932 Added 15.41%	186,728 $9.37 Million
Q2 2020 Aug 11, 2020	BUY	$42.91 - $52.5 $262,909 - $321,667	6,127 Added 3.94%	161,796 $8.26 Million
Q1 2020 May 08, 2020	SELL	$38.02 - $51.66 $333,663 - $453,368	-8,776 Reduced 5.34%	155,669 $6.81 Million
Q4 2019 Feb 07, 2020	BUY	$44.25 - $50.86 $1 Million - $1.15 Million	22,687 Added 16.0%	164,445 $8.26 Million
Q3 2019 Oct 31, 2019	SELL	$40.34 - $46.64 $439,988 - $508,702	-10,907 Reduced 7.14%	141,758 $6.57 Million
Q2 2019 Aug 09, 2019	SELL	$40.43 - $44.3 $566 - $620	-14 Reduced 0.01%	152,665 $6.61 Million
Q1 2019 Apr 24, 2019	SELL	$40.83 - $45.43 $438,881 - $488,327	-10,749 Reduced 6.58%	152,679 $6.76 Million
Q4 2018 Jan 30, 2019	SELL	$41.48 - $45.59 $1.11 Million - $1.22 Million	-26,857 Reduced 14.11%	163,428 $7.1 Million
Q3 2018 Oct 26, 2018	SELL	$40.0 - $44.84 $38,360 - $43,001	-959 Reduced 0.5%	190,285 $8.5 Million
Q2 2018 Aug 10, 2018	BUY	$37.63 - $41.22 $115,335 - $126,339	3,065 Added 1.63%	191,244 $7.65 Million
Q1 2018 May 09, 2018	BUY	$38.98 - $45.76 $1.31 Million - $1.54 Million	33,702 Added 21.82%	188,179 $7.54 Million
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $7.27 Million - $7.78 Million	154,477	154,477 $7.69 Million

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Sanofi Transaction History